UCB and Harvard unite to study the human microbiome

10/12/2012 | GenomeWeb Daily News (free registration)

Belgian biopharmaceutical company UCB has partnered with Harvard University researchers to study the species found in the human microbiome -- the bacteria living inside the human body -- and how they affect the body's immune system. The objective of the UCB-funded project is to discover new drugs for preventing or treating immunological disorders. "We hope this project will fundamentally shift the paradigm of drug development for immunological diseases, exploiting naturally occurring molecules evolutionarily designed to thwart or harness the immune system," Harvard researchers said.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
Division Manager, Math & Science
Johns Hopkins University
Baltimore, MD
K-12 Teachers Needed at Int’l Schools
The International Educator
Multiple Locations
Instructional Designer, ESL
Imagine Learning, Inc.
Provo, UT
Sr. Product Manager - Professional Development
NWEA
Nationwide, SL_Nationwide
Sr. Product Manager - Formative Assessment Product Line
NWEA
Nationwide, SL_Nationwide